4.92

2.29% 0.11

Bausch Health Companies Inc (BHC)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BHC? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$4.81

Offen:

$4.87

24-Stunden-Volumen:

1.44M

Relative Volume:

0.70

Marktkapitalisierung:

$1.84B

Einnahmen:

$10.53B

Nettoeinkommen (Verlust:

$-1.23B

KGV:

-1.5157

EPS:

-3.246

Netto-Cashflow:

$949.99M

1W Leistung:

-0.20%

1M Leistung:

-8.38%

6M Leistung:

-37.72%

1J Leistung:

-28.38%

1-Tages-Spanne:

$4.85

$5.005

1-Wochen-Bereich:

$4.74

$5.005

52-Wochen-Spanne:

$4.565

$8.685

Bausch Health Companies Inc Stock (BHC) Company Profile

Firmenname

Bausch Health Companies Inc

Sektor

Healthcare (1100)

Branche

Drug Manufacturers - Specialty & Generic (86)

Telefon

514-744-6792

Adresse

2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC

Mitarbeiter

20,300

Twitter

Nächster Verdiensttermin

2026-07-29

Neueste SEC-Einreichungen

BHC's Discussions on Twitter

Compare BHC vs TAK, HLN, TEVA, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BHC Bausch Health Companies Inc	4.92	1.80B	10.53B	-1.23B	949.99M	-3.246
TAK Takeda Pharmaceutical Co Adr	16.98	53.37B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.845	42.80B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.60	41.09B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.03	31.62B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	558.72	23.23B	3.17B	1.29B	1.01B	27.09

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Equal Weight
2024-08-02	Herabstufung	Piper Sandler	Neutral → Underweight
2024-07-10	Eingeleitet	Raymond James	Mkt Perform
2023-09-20	Hochstufung	Jefferies	Hold → Buy
2023-06-16	Herabstufung	TD Cowen	Outperform → Market Perform
2022-07-29	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2022-07-29	Herabstufung	Truist	Buy → Hold
2022-07-28	Herabstufung	JP Morgan	Overweight → Neutral
2022-06-13	Fortgesetzt	JP Morgan	Overweight
2021-03-24	Herabstufung	BofA Securities	Neutral → Underperform
2021-02-17	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2021-01-22	Herabstufung	Piper Sandler	Overweight → Neutral
2020-09-17	Hochstufung	BofA Securities	Underperform → Neutral
2020-08-24	Bestätigt	H.C. Wainwright	Buy
2020-06-17	Bestätigt	H.C. Wainwright	Buy
2020-04-24	Eingeleitet	Citigroup	Buy
2020-04-02	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-29	Herabstufung	Wolfe Research	Outperform → Peer Perform
2020-01-22	Hochstufung	Wells Fargo	Underweight → Equal Weight
2019-12-12	Hochstufung	JP Morgan	Neutral → Overweight
2019-12-02	Eingeleitet	Goldman	Neutral
2019-10-25	Eingeleitet	Cowen	Outperform
2019-09-12	Eingeleitet	Guggenheim	Buy
2019-08-15	Hochstufung	TD Securities	Hold → Buy
2019-07-19	Eingeleitet	Wolfe Research	Outperform
2019-06-11	Fortgesetzt	Barclays	Overweight
2019-05-13	Hochstufung	JP Morgan	Underweight → Neutral
2019-03-20	Eingeleitet	SunTrust	Buy
2019-01-02	Hochstufung	Piper Jaffray	Neutral → Overweight
2018-11-05	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2018-09-13	Hochstufung	Piper Jaffray	Underweight → Neutral

Alle ansehen

Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten

07:05 AM

Bausch Health plans July 29 call for Q2 results and business update - Stock Titan

07:05 AM

07:00 AM

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026 - TradingView

07:00 AM

Jul 06, 2026

Bausch Health Continues Specialty Pharma Strategy In 6 July 2026 - Kalkine Media

Jul 06, 2026

Why Did Bausch Health (TSX:BHC) Announce a Board Change? - Kalkine Media

Jul 06, 2026

Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia - Yahoo! Finance Canada

Jul 06, 2026

Jul 03, 2026

Bausch Health Companies (BHC) Posts Modest Gain, Tests Resistance ZoneETF AUM Growth - dars.gov.et

Jul 03, 2026

Jul 02, 2026

Bausch Health (BHC) director granted RSUs in lieu of cash fees - Stock Titan

Jul 02, 2026

Bausch Health (NYSE: BHC) director John Paulson granted 12,677 RSUs as board pay - Stock Titan

Jul 02, 2026

Bausch Health (NYSE: BHC) director granted 6,845 RSUs as board compensation - Stock Titan

Jul 02, 2026

Bausch Health (TSX:BHC) Board Change Follows Director Resignation - Kalkine Media

Jul 02, 2026

Best TSX Healthcare Stocks to Watch for July 2026 - Kalkine Media

Jul 02, 2026

Jul 01, 2026

Michael Goettler Resigns from Bausch Health's Board of Directors - The Globe and Mail

Jul 01, 2026

Director Michael Goettler exits Bausch Health (NYSE: BHC) board - Stock Titan

Jul 01, 2026

Bausch + Lomb survey finds dry eye affects emotional health By Investing.com - Investing.com South Africa

Jul 01, 2026

Jun 29, 2026

Why Is Bausch Health (TSX:BHC) Expanding Beyond the S&P/TSX? - Kalkine Media

Jun 29, 2026

Jun 27, 2026

BVF Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026

Bausch Health (BHC) Drops Nearly 10%: Support Levels in Focus After Sharp DeclineMean Reversion Trade - dars.gov.et

Jun 27, 2026

Price to earnings forward of Bausch Health Companies Inc. – FWB:BVF - TradingView

Jun 26, 2026

Bausch Health Companies Inc. Actuals & Estimates (NYSE:BHC) - TradingView

Jun 26, 2026

Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (FWB:BVF) - TradingView

Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (BOATS:BHC) - TradingView

Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (LSX:A2JQ1X) - TradingView

Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (BIVA:BHC/N) - TradingView

Jun 25, 2026

BHC Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Bausch Health Companies adjusts debt profile, shares react to refinancing step - AD HOC NEWS

Jun 25, 2026

Price to earnings forward of Bausch Health Companies Inc. – BOATS:BHC - TradingView

Jun 25, 2026

Jun 23, 2026